Extrapyramidal motor signs in clinically diagnosed Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 10, Issue 2, 1996, Pages 103-114

  Ellis, Ronald J ^a,b   Caligiuri, Michael ^b   Galasko, Douglas ^a,b   Thal, Leon J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Alzheimer disease; Extrapyramidal signs

Indexed keywords

NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; ARTICLE; BRADYKINESIA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LEWY BODY; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; RIGIDITY;

ALZHEIMER DISEASE; EXTRAPYRAMIDAL TRACTS; HUMANS; MOTOR ACTIVITY;

EID: 0029890323     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601020-00008     Document Type: Article

References (74)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. Washington, D.C.: American Psychiatric Association, 1987.
2. Bakchine S, Lacomblez L, Palisson E, Laurent M, Derouesne C. Relationship between primitive reflexes, extra-pyramidal signs, reflective apraxia and severity of cognitive impairment in dementia of the Alzheimer type. Acta Neurol Scand 1989;79:38-46.
3. Bergeron C, Pollanen M. Lewy bodies in Alzheimer disease - one or two diseases? Alzheimer Dis Assoc Disord 1989;3:197-204.
4. Burns A, Jacoby R, Levy R. Neurological signs in Alzheimer's disease. Age Aging 1991;20:45-51.
5. Caligiuri MP, Lohr JB, Panton D, Harris MJ. Extrapyramidal motor abnormalities associated with late-life psychosis. Schizophr Bull 1993;19:747-54.
6. Chen JY, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991;48:1141-4.
7. Chui HC, Lyness SA, Sobel E, Schneider LS. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol 1994;51:676-81.
8. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985;35:1544-50.
9. Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc 1993;41:31-7.
10. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-60.
11. Drachman DA, O'Donnell BF, Lew RA, Swearer JM. The prognosis in Alzheimer's disease. "How far" rather than "how fast" best predicts the course. Arch Neurol 1990;47:851-6.
12. Duret M, Goldman S, Messina D, Hildebrand J. Effect of L-dopa on dementia-related rigidity. Acta Neurol Scand 1989;80:64-7.
13. Ellis RJ, Grundman M, Hofstetter CR, et al. Extrapyramidal signs are independent of dementia severity in community-dwelling Alzheimer patients. Unpublished manuscript, 1995.
14. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989;262:2551-6.
15. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Golstein M, eds. Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information, 1987:153-63.
16. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
17. Forstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry 1991;162:385-92.
18. Franssen EH, Kluger A, Torossian CL, Reisberg B. The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline. Arch Neurol 1993;50:1029-39.
19. Funkenstein HH, Albert MS, Cook NR, et al. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. Arch Neurol 1993;50:51-6.
20. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51:888-95.
21. Galasko D, Kwo-on-Yuen PF, Klauber MR, Thal LJ. Neurological findings in Alzheimer's disease and normal aging. Arch Neurol 1990;47:625-7.
22. Gearing M, Mirra SS, Hedreen JC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-6.
23. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-24.
24. Gilley DW, Wilson RS, Bennett DA, Bernard BA, Fox JH. Predictors of behavioral disturbance in Alzheimer's disease. J Gerontol 1991;46:362-71.
25. Girling DM, Berrios GE. Extrapyramidal signs, primitive reflexes and frontal lobe function in senile dementia of the Alzheimer type. Br J Psychiatry 1990;157:888-93.
26. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
27. Huff FJ, Belle SH, Shim YK, et al. Prevalence and prognostic value of neurologic abnormalities in Alzheimer's disease. Dementia 1990;1:32-10.
28. Huff FJ, Boller F, Lucchelli F, et al. The neurologic examination in patients with probable Alzheimer's disease. Arch Neurol 1987;44:929-32.
29. Huff FJ, Growdon JH. Neurological abnormalities associated with seventy of dementia in Alzheimer's disease. Can J Neurol Sci 1986;135:403-5.
30. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-8.
31. Jellinger K. New developments in the pathology of Parkinson's disease. Adv Neurol 1990;53:1-16.
32. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1988;24:50-6.
33. Kaye JA, May C, Daly E, et al. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features. Neurology 1988;38:554-7.
34. Kischka U, Mandir AS, Ghika J, Growdon JH. Electrophysiologic detection of extrapyramidal motor signs in Alzheimer's disease. Neurology 1993;43:500-5.
35. Klauber M, Hofstetter C, Hill L, Thal L. Patterns of decline in the Lewy body variant of Alzheimer's disease. Arch Psychiatry (Shanghai) 1993;4:54-8.
36. Kraemer HC, Tinklenberg J, Yesavage JA. "How far" vs "how fast" in Alzheimer's disease. The question revisited. Arch Neurol 1994;51:275-9.
37. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl) 1988;75:345-53.
38. Langlais PJ, Thal L, Hansen L, et al. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993;43:1927-34.
39. Leverenz J, Sumi SM. Parkinson's disease in patients with Alzheimer's disease. Arch Neurol 1986;43:662-4.
40. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994;35:81-8.
41. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992;49:492-7.
42. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985;35:453-61.
43. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-7.
44. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 1992a;305:673-8.
45. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992b;22:911-22.
46. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
47. Merello M, Sabe L, Teson A, et al. Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1994;57:1503-9.
48. Miller TP, Tinklenberg J, Brooks JE, Yesavage JA. Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signs. Alzheimer Dis Assoc Disord 1991;5:251-6.
49. Molsa PK, Marttila RJ, Rinne UK. Extrapyramidal signs in Alzheimer's disease. Neurology 1984;34:1114-6.
50. Molsa PK, Sako E, Paljarvi L, Rinne JO, Rinne UK. Alzheimer's disease: neuropathological correlates of cognitive and motor disorders. Acta Neurol Scand 1987;75:376-84.
51. Morris JC, Drazner M, Fulling K, et al. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors? Arch Neurol 1989;46:651-7.
52. Mortimer JA, Ebbitt B, Jun SP, Rinch MD. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992;42:1689-96.
53. Murray AM, Weihmueller FB, Marshall JF, et al. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 1995;37:300-12.
54. Murray MP, Kory RC, Clarkson BH. Walking patterns in healthy old men. J Gerontol 1969;24:169-78.
55. Pearce J. The extrapyramidal disorders of Alzheimer's disease. Eur Neurol 1974;12:94-103.
56. Perry EK, Marshall E, Perry RH, et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 1990;4:87-95.
57. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-39.
58. Potvin AR, Syndulko K, Tourtellotte WW, Lemmon JA, Potvin JH. Human neurologic function and the aging process. J Am Geriatr Soc 1980;28:1-9.
59. Rajput AH. Frequency and cause of Parkinson's disease. Can J Neurol Sci 1992;195:103-7.
60. Richards M, Bell K, Dooneief G, et al. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology 1993a;43:1708-11.
61. Richards M, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Dis Assoc Disord 1993b;7:22-32.
62. Richards M, Marder K, Bell K, et al. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol 1991;48:1147-9.
63. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;43:2184-8.
64. Salthouse TA, Somberg BL. Isolating the age deficit in speeded performance. J Gerontol 1982;37:59-63.
65. Soininen H, Helkala EL, Laulumaa V, et al. Cognitive profile of Alzheimer patients with extrapyramidal signs: a longitudinal study. J Neurol 1992a;4:241-54.
66. Soininen H, Laulumaa V, Helkala EL, Hartikainen P, Reikkinen PJ. Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study. J Neural Transm 1992b;4:107-19.
67. Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993;7:3-21.
68. Stern Y, Hesdorffer D, Sano M, Mayeux R. Measurement and prediction of functional capacity in Alzheimer's disease. Neurology 1990;40:8-14.
69. Stern Y, Mayeux R, Chen JY. Predictors of mortality in Alzheimer's disease. Ann Neurol 1989;26:132.
70. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987a;37:1649-53.
71. Stern Y, Sano M, Paulson J. Modified Mini-Mental State Examination. Validity and reliability. Neurology 1987b;37:S179.
72. Thai LJ, Galasko D, Katzman R, Hill LR, Hansen L. Clinical neurological findings predict Lewy bodies associated with AD at autopsy. Neurology 1993;43:A336.
73. Webster DD. Critical analysis of the disability in Parkinson's disease. Mod Treat 1968;5:257-82.
74. Zhang ZX, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208.